Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

Ready to upgrade your sunscreen routine this summer—for free? La Roche-Posay is offering a free sample of its award-winning Anthelios Face & Body Sunscreen, and it’s as easy as signing up while ...

Posay's Effaclar collection is the gold standard. Beloved for its lightweight textures, efficacious ingredients and friendly price point, it's no wonder the range is one of the brand's bestsellers. So ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive order to cut prescription drug costs. Last month, Roche said it planned ...

But one of his recent actions could have the reverse effect, if you take Switzerland's Roche at its word. On the heels of Trump's recent "Most Favored Nation" executive order on drug pricing ...

Summer is fast approaching with the sun already having made a much welcome appearance in recent weeks. As such, many Brits have been looking to stock up on sun protection ahead of the warmer weather.

For people with early-stage HER2-positive disease, the APHINITY results validate the sustained benefits of the Perjeta-based regimen,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer ...

In parallel with approving AbbVie's antibody-drug conjugate (ADC), the agency also approved Roche's Ventana MET (SP44) RxDx Assay for identifying patients with c-Met overexpression who are eligible ...

Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. manufacturing and distribution hub for its ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit. The Swiss pharmaceutical and diagnostics giant ...